Guangzhou Boji Medical and Biotechnological Co Ltd (300404) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.008x

Based on the latest financial reports, Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has a cash flow conversion efficiency ratio of -0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.39 Million ≈ $-1.08 Million USD) by net assets (CN¥918.92 Million ≈ $134.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guangzhou Boji Medical and Biotechnological Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Guangzhou Boji Medical and Biotechnological Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Guangzhou Boji Medical and Biotechnologi for a breakdown of total debt and financial obligations.

Guangzhou Boji Medical and Biotechnological Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Boji Medical and Biotechnological Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangsu Phoenix Property Investment Co Ltd SHG:600716	0.013x
LG Balakrishnan & Bros Limited NSE:LGBBROSLTD	0.063x
Autohellas S.A. AT:OTOEL	0.064x
Fireweed Zinc Ltd V:FWZ	-0.677x
Happiest Minds Technologies Limited NSE:HAPPSTMNDS	0.018x
Pulike Biological Engineering SHG:603566	0.034x
Stendörren Fastigheter AB (publ) ST:STEF-B	0.020x
Chrysos Corporation Ltd AU:C79	0.032x

Annual Cash Flow Conversion Efficiency for Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Guangzhou Boji Medical and Biotechnologi.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.00 Billion ≈ $146.59 Million	CN¥26.78 Million ≈ $3.92 Million	0.027x	-27.12%
2023-12-31	CN¥980.11 Million ≈ $143.42 Million	CN¥35.95 Million ≈ $5.26 Million	0.037x	+15.86%
2022-12-31	CN¥888.72 Million ≈ $130.05 Million	CN¥28.14 Million ≈ $4.12 Million	0.032x	-10.97%
2021-12-31	CN¥846.38 Million ≈ $123.85 Million	CN¥30.10 Million ≈ $4.40 Million	0.036x	-82.23%
2020-12-31	CN¥485.00 Million ≈ $70.97 Million	CN¥97.07 Million ≈ $14.20 Million	0.200x	+106199.25%
2019-12-31	CN¥456.08 Million ≈ $66.74 Million	CN¥85.87K ≈ $12.57K	0.000x	-99.71%
2018-12-31	CN¥423.71 Million ≈ $62.00 Million	CN¥27.06 Million ≈ $3.96 Million	0.064x	+0.92%
2017-12-31	CN¥414.35 Million ≈ $60.63 Million	CN¥26.22 Million ≈ $3.84 Million	0.063x	+179.45%
2016-12-31	CN¥429.84 Million ≈ $62.90 Million	CN¥-34.24 Million ≈ $-5.01 Million	-0.080x	-1889.41%
2015-12-31	CN¥432.68 Million ≈ $63.32 Million	CN¥1.93 Million ≈ $281.83K	0.004x	-96.21%
2014-12-31	CN¥218.48 Million ≈ $31.97 Million	CN¥25.69 Million ≈ $3.76 Million	0.118x	-44.43%
2013-12-31	CN¥205.52 Million ≈ $30.07 Million	CN¥43.48 Million ≈ $6.36 Million	0.212x	-12.94%
2012-12-31	CN¥170.36 Million ≈ $24.93 Million	CN¥41.40 Million ≈ $6.06 Million	0.243x	--

About Guangzhou Boji Medical and Biotechnological Co Ltd

SHE:300404 China Biotechnology

Market Cap

$606.22 Million

CN¥4.14 Billion CNY

Market Cap Rank

#11545 Global

#3512 in China

Share Price

CN¥10.74

Change (1 day)

+1.42%

52-Week Range

CN¥8.19 - CN¥13.15

All Time High

CN¥297.35